Hutch News

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
1 NEW February 05, 2026
Virus researchers Cohn and Blanco-Melo win coveted grants

Virus researchers Cohn and Blanco-Melo win coveted grants

Pew and Searle scholar programs each give a boost to accomplished, early-career scientists
Hutch NewsJune 13, 2023
A promising HIV vaccine candidate gets a little help

A promising HIV vaccine candidate gets a little help

New strategy stirs a robust response from T cells tracked by McElrath lab
Hutch NewsMay 24, 2023
Infectious disease scientists look beyond the pandemic

Infectious disease scientists look beyond the pandemic

A symposium about protecting people with weakened immune systems from microbial threats
Hutch NewsMay 09, 2023
Early research may show new way to block dengue and Zika virus

Early research may show new way to block dengue and Zika virus

Scientists find different flavor of broadly neutralizing antibody that could lead to new vaccines for growing threat
Hutch NewsApril 19, 2023
Peripheral neuropathy: When having no pain is a big problem

Peripheral neuropathy: When having no pain is a big problem

Chemotherapy-induced nerve damage is common for cancer patients and difficult to treat
Hutch NewsMarch 27, 2023
Two rare antibodies, one drug, four viruses

Two rare antibodies, one drug, four viruses

Researchers discover antibodies to block RSV, other viruses that put transplant patients at risk
Hutch NewsMarch 06, 2023
Dr. Fred Appelbaum receives Lifetime Achievement award

Dr. Fred Appelbaum receives Lifetime Achievement award

Medical pioneer and longtime Fred Hutch leader honored by American Society for Transplantation and Cellular Therapy
Hutch NewsFebruary 19, 2023
How blood cancer research might help organ transplant patients

How blood cancer research might help organ transplant patients

Fred Hutch study suggests certain immune cells are source of antibodies that attack donated organs
Hutch NewsFebruary 16, 2023
Eight Fred Hutch teams win Evergreen Fund awards

Eight Fred Hutch teams win Evergreen Fund awards

Research projects with commercial partnership potential receive grants of up to $200K
Hutch NewsDecember 13, 2022
Could a 100-year-old TB vaccine help scientists find a better one?

Could a 100-year-old TB vaccine help scientists find a better one?

Harmless vaccine BCG is made of living bacteria; in tests might serve as a proxy for deadly tuberculosis
Hutch NewsDecember 12, 2022
On World AIDS Day, a broad view of continuing work

On World AIDS Day, a broad view of continuing work

Teams of Fred Hutch scientists test vaccines, treatments, new strategies
Hutch NewsDecember 01, 2022
Dr. Larry Corey receives Alexander Fleming Award

Dr. Larry Corey receives Alexander Fleming Award

Virologist honored by peers for his lifetime achievements against infectious diseases
Hutch NewsOctober 21, 2022
Researching herpes treatments with 'skin-on-chip' technology

Researching herpes treatments with 'skin-on-chip' technology

Experimental device grows human skin, infects and treats it; could advance disease modeling in labs
Hutch NewsOctober 19, 2022
Fred Hutch hosts inaugural Dr. E. Donnall Thomas Symposium

Fred Hutch hosts inaugural Dr. E. Donnall Thomas Symposium

Event draws leading researchers in transplantation, gene and cell therapy
Hutch NewsOctober 07, 2022
Researchers  refine experimental gene therapy for herpes

Researchers refine experimental gene therapy for herpes

Treatment sharply reduced viral shedding in laboratory mice
Hutch NewsSeptember 26, 2022
Fauci visits Fred Hutch, discusses pandemics, vaccines and scientific misinformation

Fauci visits Fred Hutch, discusses pandemics, vaccines and scientific misinformation

NIAID director’s determined spirit recognized with honorary Hutch Award
Hutch NewsAugust 10, 2022
Dispatches from the microbial frontier of cancer research

Dispatches from the microbial frontier of cancer research

Hutch scientists aim high by way of the lowly microorganisms that call us home
Hutch NewsJuly 15, 2022
Researchers advance development of potential Epstein-Barr virus vaccines

Researchers advance development of potential Epstein-Barr virus vaccines

Stakes raised as common virus linked to more diseases
Hutch NewsJune 14, 2022
Test of a new 'germline-targeting' HIV vaccine prepares to launch

Test of a new 'germline-targeting' HIV vaccine prepares to launch

Vaccine’s unique protein designed to start process of building powerful antibodies against AIDS virus
Hutch NewsMay 19, 2022
Solid tumors use a type of T cell as a shield against immune attack

Solid tumors use a type of T cell as a shield against immune attack

Discovery in head and neck cancers may open door for targeted immune-boosting drugs
Hutch NewsMay 11, 2022